Rapid Acting Antidepressants

Erscheinungsjahr 2020
ISBN: 978-0-12-820189-3
Verlag: William Andrew Publishing

Buch, Englisch, 402 Seiten, Format (B × H): 152 mm x 229 mm, Gewicht: 770 g

The Advances in Pharmacology series presents a variety of chapters from the best authors in the field.

Zielgruppe

<p>investigators in neuroscience, pharmacology, neurology, psychiatry, medicine. </p>

Autoren/Hrsg.

Weitere Mitwirkende

Duman, Ronald S.

Krystal, John H.

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Pharmakologie, Toxikologie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Neurologie, Klinische Neurowissenschaft
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Neuropharmakologie, Psychopharmakologie
• Interdisziplinäres Wissenschaften Wissenschaften Interdisziplinär Neurowissenschaften, Kognitionswissenschaft
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Psychiatrie, Sozialpsychiatrie, Suchttherapie

Inhaltsverzeichnis

Part I - Neurobiology of ketamine effects

- Effects of ketamine and other rapidly acting antidepressants on hippocampal excitatory and inhibitory transmission

Allie J. Widman and Lori L. McMahon

- Antidepressant mechanisms of ketamine: Focus on GABAergic inhibition

Bernhard Luscher, Mengyang Feng and Sarah J. Jefferson

- The role of eEF2 kinase in the rapid antidepressant actions of ketamine

Kanzo Suzuki and Lisa M. Monteggia

Part II - The rapid therapeutic effects of ketamine

- Clinical overview of NMDA-R antagonists and clinical practice

Pasha A. Davoudian and Samuel T. Wilkinson

- Ketamine for depression clinical issues

Syed Z. Iqbal and Sanjay J. Mathew

- Chronic stress pathology and ketamine-induced alterations in functional connectivity in major depressive disorder: An abridged review of the clinical evidence

Lynnette A. Averill, Samar Fouda, James W. Murrough and Chadi G. Abdallah

- Neurobiological biomarkers of response to ketamine

Bashkim Kadriu, Elizabeth D. Ballard, Ioline D. Henter, Stephen Murata, Nimesha Gerlus and Carlos A. Zarate Jr

- Relapse prevention in treatment resistant major depressive disorder with rapid-acting antidepressants

Jaskaran B. Singh, Maggie Fedgchin, Ella J. Daly and Wayne C. Drevets

- The emergence of ketamine as a novel treatment for posttraumatic stress disorder

Adriana Feder, Sarah B. Rutter, Daniela Schille and Dennis S. Charney

Part III - Novel rapid-acting antidepressant mechanisms related to ketamine

- mGlu2/3 receptor as a novel target for rapid acting antidepressants

Shigeyuki Chaki

- Involvement of muscarinic receptor mechanisms in antidepressant drug action

Jeffrey M. Witkin, Jodi L. Smith, Lalit K. Golani, Emily A. Brooks and Anna E. Martin

- The antidepressant efficacy of the muscarinic antagonist scopolamine: Past findings and future directions

Wayne C. Drevets, Anindya Bhattacharya and Maura L. Furey

Über Autor(innen)

Duman, Ronald S.
Ronald Duman is at Yale University School of Medicine, CT, USA

Krystal, John H.
John Krystal is at Yale University, CT, USA